Cargando…

Anti-Proliferative Effect of Cytohesin Inhibition in Gefitinib-Resistant Lung Cancer Cells

Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKI), such as gefitinib, have been proven to efficiently inhibit the proliferation of a subset of non small-cell lung cancers (NSCLC). Unfortunately, the majority of NSCLC expressing wild type EGFR is primarily resistant to EGFR-TKI...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bill, Anke, Schmitz, Anton, König, Katharina, Heukamp, Lukas C., Hannam, Jeffrey S., Famulok, Michael
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3399819/ https://www.ncbi.nlm.nih.gov/pubmed/22815959 http://dx.doi.org/10.1371/journal.pone.0041179

Ejemplares similares

A Cytohesin Homolog in Dictyostelium Amoebae
por: Shina, Maria Christina, et al.
Publicado: (2010)

Regulation of cytohesins by their interactors in the nervous system
por: Zhai, Yuqi, et al.
Publicado: (2023)

Studying the Conformation of a Receptor Tyrosine Kinase in Solution by Inhibitor‐Based Spin Labeling
por: Yin, Dongsheng M., et al.
Publicado: (2017)

Cytohesins/ARNO: The Function in Colorectal Cancer Cells
por: Pan, Tao, et al.
Publicado: (2014)

Physiological and Pathological Roles of the Cytohesin Family in Neurons
por: Ito, Akiko, et al.
Publicado: (2022)

Correction: Cytohesins/ARNO: The Function in Colorectal Cancer Cells
por: Pan, Tao, et al.
Publicado: (2015)

Cytohesin-2 Is Upregulated in Malignant Melanoma and Contributes to Tumor Growth
por: Lee, Yoon Jin, et al.
Publicado: (2019)

Inhibiting proliferation of gefitinib-resistant, non-small cell lung cancer
por: Sudo, Makoto, et al.
Publicado: (2013)

Chloroquine Enhances Gefitinib Cytotoxicity in Gefitinib-Resistant Nonsmall Cell Lung Cancer Cells
por: Tang, Mei-Chuan, et al.
Publicado: (2015)

The cytohesin paralog Sec7 of Dictyostelium discoideum is required for phagocytosis and cell motility
por: Müller, Rolf, et al.
Publicado: (2013)

The Cytohesin Coiled-Coil Domain Interacts with Threonine 276 to Control Membrane Association
por: Hiester, Kevin G., et al.
Publicado: (2013)

Design and Synthesis of New (SecinH3) Derivatives as Potential Cytohesin Inhibitors
por: Hayallah, Alaa M.
Publicado: (2014)

Data on the effect of knockout of cytohesin-1 in myelination-related protein kinase signaling
por: Tsuneishi, Ruri, et al.
Publicado: (2017)

Function and mode of action of cytohesins in the epidermal growth factor pathway in colorectal cancer cells
por: PAN, TAO, et al.
Publicado: (2013)

Stepping stone: a cytohesin adaptor for membrane cytoskeleton restraint in the syncytial Drosophila embryo
por: Liu, Jiangshu, et al.
Publicado: (2015)

Structural Dynamics Control Allosteric Activation of Cytohesin Family Arf GTPase Exchange Factors
por: Malaby, Andrew W., et al.
Publicado: (2017)

ERK inhibition represses gefitinib resistance in non-small cell lung cancer cells
por: Qi, Mengfan, et al.
Publicado: (2018)

Structural Organization and Dynamics of Homodimeric Cytohesin Family Arf GTPase Exchange Factors in Solution and on Membranes
por: Das, Sanchaita, et al.
Publicado: (2019)

Cytohesin-2/ARNO: A Novel Bridge Between Cell Migration and Immunoregulation in Synovial Fibroblasts
por: Wang, Yilin, et al.
Publicado: (2022)

Triptolide inhibits epithelial-mesenchymal transition and induces apoptosis in gefitinib-resistant lung cancer cells
por: Li, Fangqiong, et al.
Publicado: (2020)

KRAS Mutations and Primary Resistance of Lung Adenocarcinomas to Gefitinib or Erlotinib
por: Pao, William, et al.
Publicado: (2005)

Effect of aerobic exercise on acquired gefitinib resistance in lung adenocarcinoma
por: Yang, Hong, et al.
Publicado: (2021)

ARNO/cytohesin-2 regulates desensitization of the A(2A )adenosine receptor in rat pheochromocytoma cells
por: Gsandtner, Ingrid, et al.
Publicado: (2008)

Cytohesin-3 is required for full insulin receptor signaling and controls body weight via lipid excretion
por: Jux, Bettina, et al.
Publicado: (2019)

The GEF Cytohesin-2/ARNO Mediates Resistin induced Phenotypic Switching in Vascular Smooth Muscle Cells
por: Heun, Yvonn, et al.
Publicado: (2020)

Inhibition of DNA-PK by gefitinib causes synergism between gefitinib and cisplatin in NSCLC
por: Pan, Chi, et al.
Publicado: (2020)

RAC1 inhibition as a therapeutic target for gefitinib-resistant non-small-cell lung cancer
por: Kaneto, Naoki, et al.
Publicado: (2014)

FGL1 regulates acquired resistance to Gefitinib by inhibiting apoptosis in non-small cell lung cancer
por: Sun, Cuilan, et al.
Publicado: (2020)

Acquired Gefitinib-Resistant Mutation of EGFR in a Chemonaive Lung Adenocarcinoma Harboring Gefitinib-Sensitive Mutation L858R
por: Gow, Chien-Hung, et al.
Publicado: (2005)

Efficacy of chemotherapy plus gefitinib treatment in advanced non-small-cell lung cancer patients following acquired resistance to gefitinib
por: SONG, ZHENGBO, et al.
Publicado: (2013)

A SARS‐CoV‐2 Spike Binding DNA Aptamer that Inhibits Pseudovirus Infection by an RBD‐Independent Mechanism
por: Schmitz, Anton, et al.
Publicado: (2021)

A SARS‐CoV‐2 Spike Binding DNA Aptamer that Inhibits Pseudovirus Infection by an RBD‐Independent Mechanism
por: Schmitz, Anton, et al.
Publicado: (2021)

Epithelial-to-mesenchymal transition correlates with gefitinib resistance in NSCLC cells and the liver X receptor ligand GW3965 reverses gefitinib resistance through inhibition of vimentin
por: Hu, Yong, et al.
Publicado: (2017)

HMGB1-mediated autophagy promotes gefitinib resistance in human non-small cell lung cancer: HMGB1-mediated autophagy promotes gefitinib resistance
por: Lei, Tianyao, et al.
Publicado: (2022)

Clinical benefit of readministration of gefitinib for initial gefitinib-responders with non-small cell lung cancer
por: Yokouchi, Hiroshi, et al.
Publicado: (2007)

GRASP and IPCEF Promote ARF-to-Rac Signaling and Cell Migration by Coordinating the Association of ARNO/cytohesin 2 with Dock180
por: White, David T., et al.
Publicado: (2010)

Combined treatment with N‐acetylcysteine and gefitinib overcomes drug resistance to gefitinib in NSCLC cell line
por: Li, Jun, et al.
Publicado: (2019)

Axl-altered microRNAs regulate tumorigenicity and gefitinib resistance in lung cancer
por: Wang, Y, et al.
Publicado: (2014)

Overexpression of CTEN is associated with gefitinib resistance in non-small cell lung cancer
por: Lu, Xiangdong, et al.
Publicado: (2021)

Carbonic Anhydrase IX Controls Vulnerability to Ferroptosis in Gefitinib-Resistant Lung Cancer
por: Zhang, Chen, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_99hvqiqnplfsjnuv84dcbdnha7